Hyundai Pharmaceutical Co., Ltd. (KRX:004310)
South Korea · Delayed Price · Currency is KRW 3,615.00
+70.00 (1.97%)
At close: Nov 26, 2025
Hyundai Pharmaceutical Market Cap
Hyundai Pharmaceutical has a market cap or net worth of 100.05 billion as of November 26, 2025. Its market cap has decreased by -7.07% in one year.
Market Cap
100.05B
Enterprise Value
n/a
Revenue
108.14B
Ranking
n/a
PE Ratio
59.91
Stock Price
3,615.00
Market Cap Chart
Since August 30, 1995, Hyundai Pharmaceutical's market cap has increased from 28.77B to 100.05B, an increase of 247.72%. That is a compound annual growth rate of 4.20%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 25, 2025 | 98.12B | -1.12% |
| Dec 30, 2024 | 99.22B | -12.77% |
| Dec 28, 2023 | 113.76B | -14.20% |
| Dec 29, 2022 | 132.58B | -19.22% |
| Dec 30, 2021 | 164.12B | -22.93% |
| Dec 30, 2020 | 212.94B | 47.61% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 82.81T |
| Celltrion | 41.00T |
| ALTEOGEN | 28.19T |
| SK Biopharmaceuticals | 9.91T |
| ABL Bio | 9.86T |
| Yuhan | 8.73T |
| Peptron | 8.60T |
| LigaChem Biosciences | 6.49T |